Found 15 matching trials
Iparomlimab and Tuvonralimab Combined With GC in Advanced ICC PHASE2 This study is a randomized, controlled, open-label, single center clinical ...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer PHASE2 Study design: Prospective, single-arm, single-center phase II clinical stud...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites PHASE2 To evaluate the efficacy and safety of Sintilimab in Combination With S-1/o...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of Sintilimab Plus Apatinib and Chemotherapy in Patients With HER-2 Negative Microsatellite Stability (MSS) Advanced or Metastatic Gastric (GC) or Gastroesophageal Junction (GEJ) Cancer PHASE2 To evaluate the efficacy and safety of Sintilimab combined with apatinib an...
Show More Location
Affiliated Hospital of Qinghai University
Learn More & Join Trial
Sintilimab Combined With Chemotherapy as Adjuvant Treatment for Phase III GC and GEJ PHASE2 This study is a prospective, single-arm, phase II clinical study. Screening...
Show More Location
Cancer Hodpital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
Combining Chemoradiotherapy With Sintilimab in First-Line ICC N/A To evaluate the effectiveness and safety of GC (gemcitabine + cisplatin) an...
Show More Location
Zhongshan Hospital
Learn More & Join Trial
XELOX Combined With Sintilimab and HBO for Advanced or Metastatic GC/GEJC PHASE1 This study investigates the efficacy and safety of XELOX chemotherapy combi...
Show More Location
West China Hospital of Sichuan University
Learn More & Join Trial
QLS31905 in Combination With CAPOX Versus Sintilimab in Combination With CAPOX as First-line Treatment in Patients With GC/GEJ PHASE3 This study is a randomized, open, multicenter phase III clinical study desi...
Show More Location
Multiple Locations
Learn More & Join Trial
Personalized Tumor Neoantigen MRNA Therapy Adjuvant Treatment for Postoperative Pancreatic Cancer. PHASE1 This study is a single-center, open-label clinical study to evaluate the fe...
Show More Location
First Affiliated Hospital of Zhejiang University Schlool of Medicine
Learn More & Join Trial
Efficacy and Safety of SBRT Plus Gemcitabine, Cisplatin, and Sintilimab as First-Line Treatment for Unresectable Biliary Tract Cancer PHASE2 According to current clinical guidelines, first-line treatment for advanced...
Show More Location
Eastern Hepatobiliary Surgery Hospital
Learn More & Join Trial